SOURCE: Equity Spotlight

May 08, 2013 08:30 ET Announces Trade Alerts on: WSGP, ONCS, TTNP, and NDEV

NOTE TO EDITORS: The Following Is an Investment Opinion Issued by the Equity Spotlight

NEW YORK, NY--(Marketwired - May 8, 2013) - focuses on identifying the hottest small cap companies in today's market. We are the #1 source for the best penny stocks alerts.

Alerts for today are issued on the following stocks: WSGP, ONCS, TTNP, and NDEV

Western Graphite Inc. (OTCQB: WSGP) - shares closed up 6.52% at $1.45 yesterday on almost 2.5 million shares traded. Shares were trading as low as $0.55 in early April.

You can read more about WSGP here:

OncoSec Medical Incorporated (OTCQB: ONCS) traded roughly 5.6 million shares yesterday in comparison to an average of about 880,000. The Company announced on Tuesday that they will present at the Sachs Cancer Bio Partnering Forum and participate in a panel discussion on immunotherapies and cancer vaccines.

You can read more about ONCS here:

Titan Pharmaceuticals Inc. (OTCQB: TTNP) - shares continued to trend higher on Tuesday closing up 13.72% on about 3.3 million shares traded. The stock is now up over 35% this week.

You can read more about TTNP here:

Novus Acquisition & Development Corp. (PINKSHEETS: NDEV) - shares closed up 7.69% on about 3.6 million shares traded yesterday. The Company announced on Tuesday that it has acquired, as a solely owned subsidiary, Voda Technologies, Inc.

You can read more about NDEV here:

For more promising small-cap companies that look poised for upside growth, visit:

This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Information, opinions and analysis contained herein are based on sources deemed to be reliable and are subject to change without notice. A third party has hired and paid Equity Spotlight one thousand two hundred and ninety five dollars for the publication and circulation of this news release. Accordingly, certain information included herein may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. No representation, expressed or implied, is made as to the accuracy, completeness or correctness. We accept no liability for any losses arising from an investor's reliance on or use of this report. We do not and have not had any ownership interest in said third party of any kind.

Contact Information